News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|May 23, 2016

Distinguishing Melanoma From Other Skin Cancers

Episodes in this series

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 2 Detecting Melanoma That Has Spread

EP. 2 Detecting Melanoma That Has Spread

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 6 Top Concerns of Patients

EP. 6 Top Concerns of Patients

EP. 7 Additional Approaches in Advanced Melanoma

EP. 7 Additional Approaches in Advanced Melanoma

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Updated data from GOBLET Cohort 4 demonstrated activity with Reolysin plus Tecentriq in patients with third-line metastatic squamous cell anal carcinoma: © stock.adobe.com.

Reolysin and Tecentriq Treatment Elicit Responses in Third-Line Anal Cancer

January 14th 2026

Bill Potts

Advice From a Five-Time Cancer Survivor

January 14th 2026

Joe McDonough shares what message he hopes families hear when first facing a cancer diagnosis.

Joe McDonough on Supporting Families During a Childhood Cancer Diagnosis

ByJoe McDonough

January 13th 2026

Image of man.

How Lunsumio VELO Uses the Immune System in Follicular Lymphoma

ByDr. Ian Flinn

January 13th 2026

A stage 3 multiple myeloma diagnosis is significant, but new therapies are changing the outlook. Learn about your potential next steps.

Stage 3 Multiple Myeloma: A Patient’s Guide to Treatment and Outlook

January 13th 2026

Trending on CURE

Weight Loss, Swollen Face Led to Stage 2 Lung Cancer Diagnosis

FDA Accepts Besremi Application for Essential Thrombocythemia

The Current Treatment Landscape in Multiple Myeloma

Taking Back the Razor: Choosing Power in the Face of Hair Loss

Stage 3 Multiple Myeloma: A Patient’s Guide to Treatment and Outlook